Literature DB >> 18003941

Neuropathic pain: redefinition and a grading system for clinical and research purposes.

R-D Treede1, T S Jensen, J N Campbell, G Cruccu, J O Dostrovsky, J W Griffin, P Hansson, R Hughes, T Nurmikko, J Serra.   

Abstract

Pain usually results from activation of nociceptive afferents by actually or potentially tissue-damaging stimuli. Pain may also arise by activity generated within the nervous system without adequate stimulation of its peripheral sensory endings. For this type of pain, the International Association for the Study of Pain introduced the term neuropathic pain, defined as "pain initiated or caused by a primary lesion or dysfunction in the nervous system." While this definition has been useful in distinguishing some characteristics of neuropathic and nociceptive types of pain, it lacks defined boundaries. Since the sensitivity of the nociceptive system is modulated by its adequate activation (e.g., by central sensitization), it has been difficult to distinguish neuropathic dysfunction from physiologic neuroplasticity. We present a more precise definition developed by a group of experts from the neurologic and pain community: pain arising as a direct consequence of a lesion or disease affecting the somatosensory system. This revised definition fits into the nosology of neurologic disorders. The reference to the somatosensory system was derived from a wide range of neuropathic pain conditions ranging from painful neuropathy to central poststroke pain. Because of the lack of a specific diagnostic tool for neuropathic pain, a grading system of definite, probable, and possible neuropathic pain is proposed. The grade possible can only be regarded as a working hypothesis, which does not exclude but does not diagnose neuropathic pain. The grades probable and definite require confirmatory evidence from a neurologic examination. This grading system is proposed for clinical and research purposes.

Entities:  

Mesh:

Year:  2007        PMID: 18003941     DOI: 10.1212/01.wnl.0000282763.29778.59

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  658 in total

Review 1.  Invasive brain stimulation for the treatment of neuropathic pain.

Authors:  Jean-Paul Nguyen; Julien Nizard; Yves Keravel; Jean-Pascal Lefaucheur
Journal:  Nat Rev Neurol       Date:  2011-09-20       Impact factor: 42.937

2.  Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia.

Authors:  Melissa A Farmer; Anna M Taylor; Andrea L Bailey; Alexander H Tuttle; Leigh C MacIntyre; Zarah E Milagrosa; Halley P Crissman; Gary J Bennett; Alfredo Ribeiro-da-Silva; Yitzchak M Binik; Jeffrey S Mogil
Journal:  Sci Transl Med       Date:  2011-09-21       Impact factor: 17.956

Review 3.  Sensory retraining: a cognitive behavioral therapy for altered sensation.

Authors:  Ceib Phillips; George Blakey; Greg K Essick
Journal:  Atlas Oral Maxillofac Surg Clin North Am       Date:  2011-03

4.  [Pain in multiple sclerosis and neuromyelitis optica spectrum disorders].

Authors:  Hannah L Pellkofer; Tania Kümpfel
Journal:  Schmerz       Date:  2021-05-25       Impact factor: 1.107

Review 5.  Explaining pain following cancer: a practical guide for clinicians.

Authors:  Jo Nijs; Amarins J Wijma; Laurence Leysen; Roselien Pas; Ward Willaert; Wouter Hoelen; Kelly Ickmans; C Paul van Wilgen
Journal:  Braz J Phys Ther       Date:  2018-12-21       Impact factor: 3.377

Review 6.  Methadone for neuropathic pain in adults.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Roman Schumann
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

7.  Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study.

Authors:  Susana Pereira; Filipa Fontes; Teresa Sonin; Teresa Dias; Maria Fragoso; José M Castro-Lopes; Nuno Lunet
Journal:  Support Care Cancer       Date:  2015-09-18       Impact factor: 3.603

Review 8.  Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Thomas Toelle; Andrew S C Rice
Journal:  Cochrane Database Syst Rev       Date:  2014-04-27

Review 9.  Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.

Authors:  N Percie du Sert; A S C Rice
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 10.  [Neuropathic pain: pathophysiology, assessment, and therapy].

Authors:  C Sommer
Journal:  Schmerz       Date:  2013-12       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.